Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Biomedicines|July 29, 2023
The Application of Evidence-Based Medicine in Individualized MedicinePeter Van de Vliet, Tobias Sprenger, Linde F C Kampers, et al.
Anticancer Research|December 11, 2013
Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trialAn Coosemans, Anke Vanderstraeten, Sandra Tuyaerts, et al.
Oncoimmunology|April 9, 2016
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade gliomaLien Vandenberk, Abhishek D Garg, Tina Verschuere, et al.
Methods in Cell Biology|March 28, 2024
Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patientsStefaan W Van Gool, Peter Van de Vliet, Linde F C Kampers, et al.
Cytotherapy|July 17, 2016
Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno GroupStefaan W van Gool, Stefan Holm, Johannes Rachor, et al.
Stem Cells Translational Medicine|July 29, 2016
Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T LymphocytesJeroen Plessers, Emily Dekimpe, Matthias Van Woensel, et al.
Medicines (Basel, Switzerland)|May 23, 2020
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution ExperienceStefaan W Van Gool, Jennifer Makalowski, Erin R Bonner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activityJan Vermeiren, Jan L Ceuppens, Marijke Van Ghelue, et al.
Biomed Research International|September 29, 2015
Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM PatientsAdrian Ion-Margineanu, Sofie Van Cauter, Diana M Sima, et al.
Pediatric Blood & Cancer|October 24, 2009
Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumoursHilko Ardon, Steven De Vleeschouwer, Frank Van Calenbergh, et al.
Pageof 8